SUMMARY In a series of 218 patients diagnosed as having primary bilary cirrhosis only nine exhibited a negative serum mitochondrial antibody. On examining additional specimens from these. patients, seven were found to be positive, giving a final incidence of greater than 99%. The two. patients whose sera remained negative for the mitochondrial antibody had liver histology compatible with the diagnosis of primary biliary cirrhosis, but a firm diagnosis could not be reached. Free Hospital identified 218 patients with the diagnosis of primary biliary cirrhosis. In nine patients. mitochondrial antibody was negative at presentation, the diagnosis being made on the basis of symptoms, biochemistry, and liver histology. Ad--ditional specimens from these patients were examined for the presence of mitochondrial antibody. The original specimens were not available for retesting and in general the repeat specimen was obtained within one to five years.
Primary biliary cirrhosis is a disease of unknown aetiology in which the epithelium of the intrahepatic biliary tree is destroyed by a chronic inflammatory process characterised by the presence of granulomata.
The incidence of mitochondrial antibody in patients diagnosed on the basis of a suggestive clinical history, cholestatic liver function tests, raised serum IgM, and a compatible histological appearance has varied from 83 to 98%.1-6 When primary biliary cirrhosis was diagnosed at the presymptomatic stage, mitochondrial antibody was present in 90 to 100% of cases.7 8
To investigate further the specificity of the relationship of the mitochondrial antibody to primary biliary cirrhosis, we have tested a large group of patients who, on clinical, biochemical, and histological grounds, have this disease. We have also examined three apparently normal subjects who were mitochondrial antibody positive, for the presence of liver disease. Methods PATIENTS A review of the clinical and liver biopsy material from January 1973 to December 1977 at the Royal Free Hospital identified 218 patients with the diagnosis of primary biliary cirrhosis. In nine patients. mitochondrial antibody was negative at presentation, the diagnosis being made on the basis of symptoms, biochemistry, and liver histology. Ad--ditional specimens from these patients were examined for the presence of mitochondrial antibody. The original specimens were not available for retesting and in general the repeat specimen was obtained within one to five years.
Three additional subjects were included in the study. All were mitochondrial antibody positivewith normal alkaline phosphatase and IgM. These patients were studied clinically, biochemically, serologically, and histologically for stigmata of primary biliary cirrhosis. IgM (0 7-2-8 g/l (70-280 mg %)) IgG (8-18 g/l (800-1800 mg%)) IgA (0.9-4.5 g/l (90-450 mg %)) The nine patients who were initially negative for mitochondrial antibody had a clinical history, LFTs, and histological changes suggestive of primary biliary cirrhosis when first presenting to medical care. They were all females and the mean age was 48 years (34 to 70 years). IgM was raised in five patients. Patient 4 had low serum levels of alpha 1 antitrypsin (0.9 g/l (92 mg%) normal, 1.9 g/l (190 mg%)). Liver biopsy of this patient showed some PAS-diastase resistant globules in hepatocytes. It was not possible to make additional studies as there was no follow-up in this patient. Extrahepatic bile ducts were shown to be clear in all the patients.
The liver biopsies of the nine patients were randomised and reviewed by a single observer. A total of 16 liver biopsies were reviewed. There was no marked differences between the patients who remained negative for serum mitochondrial antibody and the patients who were found to be positive for this antibody on retesting. All the patients had stage 3 or 4 of primary biliary cirrhosis.9
Two patients remained negative for serum mitochondrial antibody (patients 1-2) ( Table 2) . One patient, in spite of normal levels of IgM, had clinical, biochemical, and histological data suggestive of primary biliary cirrhosis. Her liver biopsy is shown in Fig. 1 . She had Sicca syndrome at the time of presentation and two years later developed renal tubular acidosis. This patient was treated with D-penicillamine which over 16 months produced a fall in liver copper from 683 ,um/g to 77 ,um/g dry liver.
Patient 2 developed itching during pregnancy. After delivery she developed jaundice and hepatosplenomegaly. She was first seen at the Royal Free Fig. 1 4% on initial screening. However, on retesting additional specimens and using undiluted serum, only two patients remained negative for this antibody.
Four of the seven patients who, on retesting, were found to be positive for the antibody had low titres at the limit of the sensitivity of the test. Differences in results obtained between the two laboratories emphasise the subjectivity of the immunofluoresence test system, particularly with low titre specimens. It is noteworthy that patient 4 had a positive mitochondrial antibody at the Middlesex Hospital only in undiluted serum. However, the incidence of false positive results must be determined before we can be sure that testing undiluted serum is generally useful. There were three patients (patient 6, 7, 9) who were found to have high mitochondrial antibody titre on Fig. 2 This study suggests that 'mitochondrial antibody negative' primary biliary cirrhosis either has an extremely low incidence or it does not exist. Before making this diagnosis the mitochondrial antibody should probably be sought on several occasions in undiluted sera if necessary. In addition, other causes of intrahepatic cholestasis such as alpha 1 antitrypsin deficiency or sclerosing cholangitis must be considered.
Mitochondrial antibody has been detected in conditions other than PBC such as chronic active hepatitis and cryptogenic cirrhosis.3 However, the mitochondrial antibody in chronic active hepatitis may be of a different specificity from that found in primary biliary cirrhosis.1" Furthermore, patients with cryptogenic cirrhosis who were positive for mitochondrial antibody test were middle-aged women with cholestatic liver function tests and liver biopsies appearance somewhat similar to primary biliary cirrhosis.35 Thus these may represent a late stage of primary biliary cirrhosis.
The mitochondrial antibody has also been reported in patients with collagen disease'213: these patients also showed abnormalities in liver histology,'2 some of which might represent early primary biliary cirrhosis. Positive results have also been reported in normal subjects who did not have biopsies but have shown absence of symptoms.'4 In this study similar subjects who had normal alkaline phosphatase and IgM have been shown to have early primary biliary cirrhosis. We, therefore, suggest that in many instances where the mitochondrial antibody was said to be associated with conditions other than primary biliary cirrhosis, the diagnosis of primary biliary cirrhosis had not been adequately excluded. Even in asymptomatic subjects with normal liver function tests, the presence of the mitochondrial antibody may indicate the presence of intrahepatic lesions of primary biliary cirrhosis. These data strongly suggest that, if the mitochondrial antibody is positive, the diagnosis is likely to be primary biliary cirrhosis. 
